title: Glycosaminoglycans in nerve injury: 1. Low doses of glycosaminoglycans promote neurite formation.
abstract: This study has shown that glycosaminoglycans added to the culture medium may affect neurite formation in SH-SY5Y neuroblastoma cells. The most effective glycosaminoglycans are heparin and COS 8, a preparation with low anticoagulant activity. Promotion of neuritogenesis was remarkable at concentrations as low as 10(-8) and 10(-10). When added at 10(-4) M both agents are inhibitory. Chondroitin-4 sulfate, dermatan sulfate, and heparan sulfate were also effective, the doses required were, however, as high as 10(-4) M for promoting and 10(-4) M for inhibiting neuritogenesis. Thereby low doses of glycosaminoglycans promote, while higher doses inhibit neurite formation. The effects were observed when neuritogenesis was promoted in neuroblastoma cultures either by deprivation of serum or by addition of retinoic acid, in the former case neuritogenesis occurred within 48 hr; in the latter, in 14 days. PC12 pheochromocytoma cells neuritogenesis was triggered by adding NGF to the culture medium. We have also observed that glycosaminoglycan supplementation to the culture medium lowered the quantity of NGF required to form neurites by PC12 cells. Glycosaminoglycans at the dose of 10(-8) M allow the formation of PC12 neurites even in presence of 1 ng/ml NGF, a dose that normally is ineffective.
authors.affiliation: Laboratory for Research on Pharmacology of Neurodegenerative Disorders, Dept. Medical Pharmacology, Milano, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Lesma
authors.forename: A M
authors.initials: AM
authors.lastname: Di Giulio
authors.forename: L
authors.initials: L
authors.lastname: Ferro
authors.forename: G
authors.initials: G
authors.lastname: Prino
authors.forename: A
authors.initials: A
authors.lastname: Gorio
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006025:Glycosaminoglycans / Q000008:administration & dosage / Q000494:pharmacology*; D006493:Heparin / Q000494:pharmacology; D009414:Nerve Growth Factors / Q000494:pharmacology; D016501:Neurites / Q000187:drug effects*; D009447:Neuroblastoma / Q000473:pathology; D009474:Neurons / Q000187:drug effects*; D016716:PC12 Cells / Q000187:drug effects; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured / Q000187:drug effects
chemical_list: C105070:COS 8 preparation; D006025:Glycosaminoglycans; D009414:Nerve Growth Factors; D006493:Heparin; D013755:Tetradecanoylphorbol Acetate